Writing
The Accudopa Project
@AccudopaTracked since May 2026
Finding better ways to live with levodopa..
Observed Aug 17, 2026 · stalePublic earnings
Paid members
4
0% · 30-day rate from 12 observed days
Total audience
20
incl. free followers
Observed monthly earnings
$30
Starting price
$5/mo
3 membership tiers
Where the 20 observed tier members sit
Membership tiers$080%$1015%
Largest observed tier is $0 Free. Tier totals include free-tier members and come from the Aug 17, 2026 public snapshot, so they do not reconcile to the paid-member total.
$0/moFree1680% of observed tier members
$5/moFriend of the Project15% of observed tier members
$10/moAccudopa Insider315% of observed tier members
Growth signals: The Accudopa Project
0%
Membership4 paid members · 30-day rate from 12 observed days
454
May 202617 weeks trackedNow
The Accudopa Project4 members · $30/mo
The chart only uses The Accudopa Project's observed public history. Comparison peers are listed below, but comparable trend series are not available yet.
Where The Accudopa Project ranks
Creator comparisonsCompare within
Not enough data1 of 4 cohort creators measured
30-day member gain in Recommended cohort
Semantic matches are not ready, so this fixed cohort uses the best available category, audience, pricing, and cadence evidence.
Only The Accudopa Project has a comparable public 30-day member gain; at least one measured peer is needed for a cohort rank.Ranking data · includes stale rows| Rank | Creator and why included | 30-day member gain | Gap vs The Accudopa Project | Freshness |
|---|---|---|---|---|
| Not ranked |  The Accudopa ProjectProfileWriting30-day member gain position in Recommended cohort | 0 | Reference | Aug 17, 2026Stale |
| Not ranked |  CRAVEN Something ScaryWritingCategory, audience, pricing & cadence | 30-day comparison unavailable | Not comparable | Aug 17, 2026 |
| Not ranked |  Cripping Up SexWritingCategory, audience, pricing & cadence | 30-day comparison unavailable | Not comparable | Aug 17, 2026 |
| Not ranked |  CrotoWritingCategory, audience, pricing & cadence | 30-day comparison unavailable | Not comparable | Aug 17, 2026 |
The rank uses the full fixed cohort. This table shows up to five creators around The Accudopa Project; the coverage summary above still counts everyone.
Recent posts
What they publish88Posts total1 postLast month41.7%Members-only
Previews available for 88 posts
Article Latest postPublicLevodopa-eating bacteria? In MY microbiome?The gut microbiome – the bacteria, fungi, and other things living in your gut – is one of my favourite areas of modern research. They change
August 9 0 likes 0 commentsComing soon: anxiety!If you're someone using levodopa, you probably shuddered at that headline. It will come as no surprise to you that many with Parkinson's (and related conditions) have substantially higher rates of depression and anxiety than the general population. Due to a holiday we're releasing this week's article later than normal, but it's indeed in the works. Stay tuned!ImageFebruary 16Public 0 0We got accepted into a startup competition!Hello all! Great news: we got past the first round of a local startup competition. This is important because to work on this project regularImageSep 24, 2025Public 0 0
Wide awake, barely awake: the effects of dopamine on sleepLevodopa-responsive conditions like Parkinson’s are usually defined by their motor symptoms, but up to 90% of people with these conditions sArticleFebruary 2Public 0 0
Oh look, we won!I'm extremely happy to say that we won Co.Launch this year! The other competitors were fantastic, and we're honoured to be the top recipientArticleFebruary 2Public 0 0
Happy Canada Day (and a small delay!)Hello all! I will be away for the Canada Day week, so you'll see the usual post the week thereafter. Wish me luck with the weather! (It is Very Wet ™️ in our part of the country right now. 😬)ImageJune 30Public 0 0Predictable progression: The long-term evolution of Parkinson’s diseaseParkinson's disease, especially its medication, has a reputation for being unpredictable. The picture changes with a longer view: research tArticleJune 22$5 tier & up 0 0
What the latest research says about gender, hormones, and levodopaLevodopa-responsive conditions affect men and women differently. Gender-specific guidelines are rare or non-existent, which means those diffArticleOct 1, 2025$5 tier & up 4 2
Apples and Oranges: One simple trick to convert everything to levodopaAs regular readers will know, excess levodopa can lead to side effects like dyskinesia, personality changes, and anxiety. To combat this, peArticleJune 3$5 tier & up 0 0
A tour of dopamine agonists (including the ones that come from fungus!)Levodopa remains the gold standard for managing Parkinson's disease symptoms but comes with challenges. As your needs increase there is incrArticleMay 15$5 tier & up 0 0
Uniting the Prairies: Lessons Learned from a Major Startup ConferenceLast week a major startup event, Uniting the Prairies, made its yearly appearance in Saskatoon. The event brings startups and investors fromImageMay 6$5 tier & up 0 0
Pregnant with Parkinson's: what we know (and what we don't)Between 5 and 10 percent of people with Parkinson's are diagnosed before age 40. With families having children later in life we should thereArticleApril 21Public 0 0
Research actions
Work with this creator
Save, compare, or return to the Explore view you came from.